-
1
-
-
25444476035
-
Jaw avascular bone necrosis associated with long-term use of biphosphonates
-
Sanna G., Zampino M.G., Pelosi G., Nole F., and Goldhirsch A. Jaw avascular bone necrosis associated with long-term use of biphosphonates. Ann Oncol 16 (2005) 1207-1208
-
(2005)
Ann Oncol
, vol.16
, pp. 1207-1208
-
-
Sanna, G.1
Zampino, M.G.2
Pelosi, G.3
Nole, F.4
Goldhirsch, A.5
-
3
-
-
0042861578
-
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic
-
Marx R. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115-1117
-
(2003)
J Oral Maxillofac Surg
, vol.61
, pp. 1115-1117
-
-
Marx, R.1
-
4
-
-
27344453813
-
Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment
-
Marx R., Sawatari Y., Fortin M., and Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63 (2005) 1567-1575
-
(2005)
J Oral Maxillofac Surg
, vol.63
, pp. 1567-1575
-
-
Marx, R.1
Sawatari, Y.2
Fortin, M.3
Broumand, V.4
-
5
-
-
0642316721
-
Bisphosphanates and oral cavity avascular bone necrosis
-
Migliorati C.A. Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol 21 (2003) 4253-4254
-
(2003)
J Clin Oncol
, vol.21
, pp. 4253-4254
-
-
Migliorati, C.A.1
-
6
-
-
20544464439
-
Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone
-
Migliorati C., Schubert M., and Peterson D. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone. Cancer 104 (2005) 83-93
-
(2005)
Cancer
, vol.104
, pp. 83-93
-
-
Migliorati, C.1
Schubert, M.2
Peterson, D.3
-
7
-
-
0036721078
-
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid
-
Wood J., Bonjean K., Ruetz S., et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302 (2002) 1055-1061
-
(2002)
J Pharmacol Exp Ther
, vol.302
, pp. 1055-1061
-
-
Wood, J.1
Bonjean, K.2
Ruetz, S.3
|